Company Filing History:
33 out of 2,893 
7 out of 1,373 
4 out of 15 
Years Active: 1990-2025
Title: **Frederick M. Ausubel: Innovator in Antibiotic and Antifungal Compounds**
Introduction
Frederick M. Ausubel, a prominent inventor based in Newton, MA, has made significant contributions to the field of medical science through his extensive research and development of antibiotic and antifungal compounds. With a remarkable portfolio of 36 patents, his work continues to advance treatments for bacterial and fungal infections.
Latest Patents
Among his latest patents, Ausubel has focused on antibiotic compounds that offer new methods for treating bacterial infections. These innovations include treatments for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). His patent applications detail synthetic retinoid compounds that show promise in combating these challenging infections. Furthermore, Ausubel's work includes the development of a tricyclic fluoroquinolone compound, Z3060, which aims to treat similar bacterial infections effectively. Additionally, his research has unveiled auranofin, a gold compound that may be effective against both bacterial and fungal infections.
Career Highlights
Frederick M. Ausubel has had a distinguished career, working with notable institutions such as The General Hospital Corporation and Brigham and Women's Hospital, Inc. His dedication to scientific research in antibiotics and antifungals showcases his commitment to improving public health through innovative medical solutions.
Collaborations
Throughout his journey, Ausubel has collaborated with esteemed colleagues in the field, including Eleftherios Mylonakis and James L. Michel. These collaborations have undoubtedly enriched his research endeavors and contributed to the successful development of his patent portfolio.
Conclusion
Frederick M. Ausubel’s impactful work in the development of antibiotic and antifungal compounds underscores his significance as an inventor in the medical field. His 36 patents reflect a relentless pursuit of innovation aimed at addressing some of the most pressing challenges in treating bacterial and fungal infections. As research continues, Ausubel's contributions will undoubtedly play a crucial role in the future of medical therapies.